High content screening: seeing is believing
- PMID: 20346526
- DOI: 10.1016/j.tibtech.2010.02.005
High content screening: seeing is believing
Abstract
High content screening (HCS) combines the efficiency of high-throughput techniques with the ability of cellular imaging to collect quantitative data from complex biological systems. HCS technology is integrated into all aspects of contemporary drug discovery, including primary compound screening, post-primary screening capable of supporting structure-activity relationships, and early evaluation of ADME (absorption, distribution, metabolism and excretion)/toxicity properties and complex multivariate drug profiling. Recently, high content approaches have been used extensively to interrogate stem cell biology. Despite these dramatic advances, a number of significant challenges remain related to the use of more biology- and disease-relevant cell systems, the development of informative reagents to measure and manipulate cellular events, and the integration of data management and informatics.
Copyright 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
Impact of new technologies for cellular screening along the drug value chain.Drug Discov Today. 2010 May;15(9-10):384-90. doi: 10.1016/j.drudis.2010.02.010. Epub 2010 Mar 3. Drug Discov Today. 2010. PMID: 20206290 Review.
-
Application of a rapid and integrated analysis system (RIAS) as a high-throughput processing tool for in vitro ADME samples by liquid chromatography/tandem mass spectrometry.J Biomol Screen. 2011 Mar;16(3):370-7. doi: 10.1177/1087057110397358. Epub 2011 Feb 18. J Biomol Screen. 2011. PMID: 21335598
-
Hypothesis-driven screening.Methods Mol Biol. 2009;575:297-316. doi: 10.1007/978-1-60761-274-2_13. Methods Mol Biol. 2009. PMID: 19727621
-
Integrated expressional analysis: application to the drug discovery process.Methods. 2005 Nov;37(3):280-8. doi: 10.1016/j.ymeth.2005.03.013. Methods. 2005. PMID: 16308157
-
Genetic interventions in mammalian cells; applications and uses in high-throughput screening and drug discovery.Cell Biol Toxicol. 2010 Feb;26(1):43-55. doi: 10.1007/s10565-009-9140-z. Epub 2009 Nov 11. Cell Biol Toxicol. 2010. PMID: 19904619 Review.
Cited by
-
Patient-derived stem cells: pathways to drug discovery for brain diseases.Front Cell Neurosci. 2013 Mar 27;7:29. doi: 10.3389/fncel.2013.00029. eCollection 2013. Front Cell Neurosci. 2013. PMID: 23543597 Free PMC article.
-
GEMA-An Automatic Segmentation Method for Real-Time Analysis of Mammalian Cell Growth in Microfluidic Devices.J Imaging. 2022 Oct 14;8(10):281. doi: 10.3390/jimaging8100281. J Imaging. 2022. PMID: 36286375 Free PMC article.
-
Membrane-integrated microfluidic device for high-resolution live cell imaging.Biomicrofluidics. 2011 Dec;5(4):46501-465016. doi: 10.1063/1.3647824. Epub 2011 Oct 17. Biomicrofluidics. 2011. PMID: 22662065 Free PMC article.
-
Designs and concept reliance of a fully automated high-content screening platform.J Lab Autom. 2012 Oct;17(5):359-69. doi: 10.1177/2211068212453311. Epub 2012 Jul 12. J Lab Autom. 2012. PMID: 22797489 Free PMC article.
-
High-Throughput Methods in the Discovery and Study of Biomaterials and Materiobiology.Chem Rev. 2021 Apr 28;121(8):4561-4677. doi: 10.1021/acs.chemrev.0c00752. Epub 2021 Mar 11. Chem Rev. 2021. PMID: 33705116 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
